Related Experiment Video
Updated: Jan 14, 2026

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
Dysphagia and oropharyngeal bradykinesia in Parkinson's disease
Fabrizio Stocchi1,2, Eleonora Annese3, Fabiana Radicati3,4
1Department of Neurology, Institute for Research and Medical Care San Raffaele Roma, via della Pisana 235, 00163, Rome, RM, Italy. fabrizio.stocchi@uniroma5.it.
Abstract:
Dysphagia is a manifestation of swallowing dysfunction frequently observed in Parkinson's disease (PD). It can lead to serious clinical consequences when the patient experience aspiration or chest infections. Even in less severe cases, dysphagia significantly affects patients' quality of life. Understanding the pathophysiology underlying PD-related dysphagia is important for proper classification and for objectifying swallowing abnormalities with clinical evaluation. This review explores the mechanisms of swallowing, the various aspect of swallowing abnormalities, and their impact on the quality of life of PD patients-especially in relation to impaired responses to levodopa-and discusses suggested therapeutic approaches. In our opinion, true dysphagia in PD is less common than often believed. Swallowing difficulties may reflect oropharyngeal and/or lingual bradykinesia. Hypokinesia, a hallmark motor symptom of PD, may affect swallowing reflex and result in prolonged pharyngeal reflex times due to slow, sequential muscle movements. Symptoms such ad difficulty swallowing, food retention, sensation of food in the esophagus, and the need to drink liquids to aid bolus transit are more indicative of bradykinesia than dysphagia. Therefore, swallowing abnormalities should be carefully assessed and properly classified, with tailored pharmacological treatment and dietary adjustments for each individual case.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Deglutition
Swallowing can be divided into three stages: the voluntary phase, the pharyngeal phase, and the esophageal phase. Although the...
Gastrointestinal Motility Disorders

